Morningstar® Stock Report™

Core Laboratories Inc CLB

Balance Sheet Items (in % Terms)
20182019202020212022
Cash & Short Term Investments2.02%1.43%2.43%3.05%2.67%
Deudores19.91%16.99%14.63%16.67%18.49%
Existencias7.04%6.48%6.71%7.82%10.45%
Otros activos corrientes6.63%3.67%5.40%5.01%5.00%
Total activos corrientes35.60%28.56%29.17%32.55%36.60%
Net PP&E18.94%25.71%31.95%29.67%27.22%
Intangibles35.83%29.80%19.00%18.52%18.49%
Otros activos a largo plazo9.63%15.92%19.88%19.26%17.69%
Total Activo 100.00%100.00%100.00%100.00%100.00%
Accounts Payable6.34%4.60%4.05%5.12%7.93%
Deuda corriente-----
Impuestos a pagar1.60%1.90%2.62%2.14%1.36%
Accrued liabilities3.48%3.45%4.67%3.59%4.05%
Otro pasivo corriente4.38%4.47%4.45%4.78%4.50%
Total pasico corriente15.80%14.41%15.78%15.63%17.83%
Deuda a largo plazo44.66%39.41%45.63%32.48%29.81%
Otras deudas a largo plazo-----
Total Pasivo-----
Fondos propios totales24.16%22.96%12.58%26.93%31.86%
Total Liabilities and Equity100.00%100.00%100.00%100.00%100.00%
Liquidity/Financial Health
20182019202020212022
Current Ratio2.251.981.852.082.05
Quick Ratio1.521.341.191.371.27
Financial Leverage4.144.367.953.713.14
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures